| 
      
        | Variable | Crude Analysis | Adjusted Analysis* |  
        | Odds Ratio  (95% CI) | P value | Odds Ratio (95%    CI) | P value |  
        | Age in years | 1.0    (0.95-1.04) | 0.8 | - | - |  
        | Race/Ethnicity |  
        | Non-hispanic    white | Reference | - | - | - |  
        | Non-hispanic    black | 1.52    (0.47-4.9) | - | - | - |  
        | Other | 1.33    (0.18-9.73) | 0.78 | - | - |  
        | Weight in Kg | 0.99    (0.97-1.01) | 0.33 | 0.99 (0.96-1.01) | 0.24 |  
        | Gender |  
        | Male | Reference | - | - | - |  
        | Female | 0.5    (0.15-1.66) | 0.26 | - | - |  
        | TDF stopped |  
        | No | Reference | - | - | - |  
        | Yes | 2.54    (0.97-6.64) | 0.06 | 3.76    (1.26-11.27) | 0.02 |  
        | Increase    in sCr ≥0.3 mg/dl | 1.00 (0.87-1.15) | 0.97 | 0.75    (0.45-1.23) | 0.25 |  
        | Baseline CKD1 |  
        | No | Reference | - | - | - |  
        | Yes | 0.16    (0.04-0.68) | 0.01 | - |  |  
        | HCV Antibody |  
        | Negative | Reference | - | - | - |  
        | Positive | 2.32    (0.69-7.81) | 0.18 | - | - |  
        | Diabetes Mellitus |  
        | No | Reference |  | Reference |  |  
        | Yes | 0.63    (0.18-2.2) | 0.46 | 0.29 (0.06-1.48) | 0.14 |  
        | Hypertension |  
        | No | Reference |  | Reference |  |  
        | Yes | 1.09    (0.42-2.81) | 0.86 | 1.59    (0.45-5.66) | 0.47 |  
        | Nephrotoxic drugs |  
        | No | Reference |  | Reference |  |  
        | Yes | 1.16    (0.46–2.96) | 0.76 | 1.34    (0.43-4.21) | 0.61 |  
        | HIV-1 PVL2 |  
        | ≤75    log10 copies/ml | Reference |  |  |  |  
        | >75    log10 copies/ml | 0.52    (0.18-1.54) | 0.24 |  |  |  
        | CD4 cell count2 |  
        | ≤200    cells/µL | Reference |  |  |  |  
        | >200    cells/µL | 0.86    (0.33-2.21) | 0.75 |  |  |  |